March 2020 FDA Recall Drug by Jubilant Draximage Inc
D-1062-2020 - Failed Stability Specifications
This Class II drug recall was voluntarily initiated by Jubilant Draximage Inc on March 19, 2020 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed in Product was distributed throughout the United States. and the recall is currently terminated.
Recall Number: D-1062-2020
Failed Stability Specifications
03-19-2020
04-01-2020
473 kits of 30 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Jubilant Draximage Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Product was distributed throughout the United States.
05-19-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
DRAXIMAGE DTPA (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M PENTETATE INJECTION), 20 mg vial, Rx only, Manufactured for: Jubilant Draximage, Inc., Kirkland, Quebec, Canada, NDC 65174-288-05, 67175-288-30
Batch or Lot Expiration Information
Lot# 8K143, Exp 10/31/2020.